CHST15 Antibody Market - Global Outlook and Forecast 2022-2028

January 2022 | 107 pages | ID: C1468EA303C1EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of CHST15 Antibody in Global, including the following market information:

Global CHST15 Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global CHST15 Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Above 90% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of CHST15 Antibody include Thermo Fisher Scientific, R&D Systems, Novus Biologicals, Abcam, Bio-Rad, Boster Bio, Lifespan Biosciences, Santa Cruz Biotechnology and RayBiotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CHST15 Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global CHST15 Antibody Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global CHST15 Antibody Market Segment Percentages, by Type, 2021 (%)

• Above 90%
• Above 95%
• Above 99%
• Others

Global CHST15 Antibody Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global CHST15 Antibody Market Segment Percentages, by Application, 2021 (%)

• Biopharmaceutical Companies
• Hospitals
• Bioscience Research Institutions
• Others

Global CHST15 Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global CHST15 Antibody Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies CHST15 Antibody revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies CHST15 Antibody revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• R&D Systems
• Novus Biologicals
• Abcam
• Bio-Rad
• Boster Bio
• Lifespan Biosciences
• Santa Cruz Biotechnology
• RayBiotech
• Origene
• Genetex
• Biobyt
• Aviva Systems Biology
• Atlas Antibodies
• Abbexa Ltd
• Bioss Antibodies

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 CHST15 Antibody Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global CHST15 Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CHST15 ANTIBODY OVERALL MARKET SIZE

2.1 Global CHST15 Antibody Market Size: 2021 VS 2028
2.2 Global CHST15 Antibody Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top CHST15 Antibody Players in Global Market
3.2 Top Global CHST15 Antibody Companies Ranked by Revenue
3.3 Global CHST15 Antibody Revenue by Companies
3.4 Top 3 and Top 5 CHST15 Antibody Companies in Global Market, by Revenue in 2021
3.5 Global Companies CHST15 Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 CHST15 Antibody Players in Global Market
  3.6.1 List of Global Tier 1 CHST15 Antibody Companies
  3.6.2 List of Global Tier 2 and Tier 3 CHST15 Antibody Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global CHST15 Antibody Market Size Markets, 2021 & 2028
  4.1.2 Above 90%
  4.1.3 Above 95%
  4.1.4 Above 99%
  4.1.5 Others
4.2 By Type - Global CHST15 Antibody Revenue & Forecasts
  4.2.1 By Type - Global CHST15 Antibody Revenue, 2017-2022
  4.2.2 By Type - Global CHST15 Antibody Revenue, 2023-2028
  4.2.3 By Type - Global CHST15 Antibody Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global CHST15 Antibody Market Size, 2021 & 2028
  5.1.2 Biopharmaceutical Companies
  5.1.3 Hospitals
  5.1.4 Bioscience Research Institutions
  5.1.5 Others
5.2 By Application - Global CHST15 Antibody Revenue & Forecasts
  5.2.1 By Application - Global CHST15 Antibody Revenue, 2017-2022
  5.2.2 By Application - Global CHST15 Antibody Revenue, 2023-2028
  5.2.3 By Application - Global CHST15 Antibody Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global CHST15 Antibody Market Size, 2021 & 2028
6.2 By Region - Global CHST15 Antibody Revenue & Forecasts
  6.2.1 By Region - Global CHST15 Antibody Revenue, 2017-2022
  6.2.2 By Region - Global CHST15 Antibody Revenue, 2023-2028
  6.2.3 By Region - Global CHST15 Antibody Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America CHST15 Antibody Revenue, 2017-2028
  6.3.2 US CHST15 Antibody Market Size, 2017-2028
  6.3.3 Canada CHST15 Antibody Market Size, 2017-2028
  6.3.4 Mexico CHST15 Antibody Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe CHST15 Antibody Revenue, 2017-2028
  6.4.2 Germany CHST15 Antibody Market Size, 2017-2028
  6.4.3 France CHST15 Antibody Market Size, 2017-2028
  6.4.4 U.K. CHST15 Antibody Market Size, 2017-2028
  6.4.5 Italy CHST15 Antibody Market Size, 2017-2028
  6.4.6 Russia CHST15 Antibody Market Size, 2017-2028
  6.4.7 Nordic Countries CHST15 Antibody Market Size, 2017-2028
  6.4.8 Benelux CHST15 Antibody Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia CHST15 Antibody Revenue, 2017-2028
  6.5.2 China CHST15 Antibody Market Size, 2017-2028
  6.5.3 Japan CHST15 Antibody Market Size, 2017-2028
  6.5.4 South Korea CHST15 Antibody Market Size, 2017-2028
  6.5.5 Southeast Asia CHST15 Antibody Market Size, 2017-2028
  6.5.6 India CHST15 Antibody Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America CHST15 Antibody Revenue, 2017-2028
  6.6.2 Brazil CHST15 Antibody Market Size, 2017-2028
  6.6.3 Argentina CHST15 Antibody Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa CHST15 Antibody Revenue, 2017-2028
  6.7.2 Turkey CHST15 Antibody Market Size, 2017-2028
  6.7.3 Israel CHST15 Antibody Market Size, 2017-2028
  6.7.4 Saudi Arabia CHST15 Antibody Market Size, 2017-2028
  6.7.5 UAE CHST15 Antibody Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific CHST15 Antibody Major Product Offerings
  7.1.4 Thermo Fisher Scientific CHST15 Antibody Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 R&D Systems
  7.2.1 R&D Systems Corporate Summary
  7.2.2 R&D Systems Business Overview
  7.2.3 R&D Systems CHST15 Antibody Major Product Offerings
  7.2.4 R&D Systems CHST15 Antibody Revenue in Global Market (2017-2022)
  7.2.5 R&D Systems Key News
7.3 Novus Biologicals
  7.3.1 Novus Biologicals Corporate Summary
  7.3.2 Novus Biologicals Business Overview
  7.3.3 Novus Biologicals CHST15 Antibody Major Product Offerings
  7.3.4 Novus Biologicals CHST15 Antibody Revenue in Global Market (2017-2022)
  7.3.5 Novus Biologicals Key News
7.4 Abcam
  7.4.1 Abcam Corporate Summary
  7.4.2 Abcam Business Overview
  7.4.3 Abcam CHST15 Antibody Major Product Offerings
  7.4.4 Abcam CHST15 Antibody Revenue in Global Market (2017-2022)
  7.4.5 Abcam Key News
7.5 Bio-Rad
  7.5.1 Bio-Rad Corporate Summary
  7.5.2 Bio-Rad Business Overview
  7.5.3 Bio-Rad CHST15 Antibody Major Product Offerings
  7.5.4 Bio-Rad CHST15 Antibody Revenue in Global Market (2017-2022)
  7.5.5 Bio-Rad Key News
7.6 Boster Bio
  7.6.1 Boster Bio Corporate Summary
  7.6.2 Boster Bio Business Overview
  7.6.3 Boster Bio CHST15 Antibody Major Product Offerings
  7.6.4 Boster Bio CHST15 Antibody Revenue in Global Market (2017-2022)
  7.6.5 Boster Bio Key News
7.7 Lifespan Biosciences
  7.7.1 Lifespan Biosciences Corporate Summary
  7.7.2 Lifespan Biosciences Business Overview
  7.7.3 Lifespan Biosciences CHST15 Antibody Major Product Offerings
  7.7.4 Lifespan Biosciences CHST15 Antibody Revenue in Global Market (2017-2022)
  7.7.5 Lifespan Biosciences Key News
7.8 Santa Cruz Biotechnology
  7.8.1 Santa Cruz Biotechnology Corporate Summary
  7.8.2 Santa Cruz Biotechnology Business Overview
  7.8.3 Santa Cruz Biotechnology CHST15 Antibody Major Product Offerings
  7.8.4 Santa Cruz Biotechnology CHST15 Antibody Revenue in Global Market (2017-2022)
  7.8.5 Santa Cruz Biotechnology Key News
7.9 RayBiotech
  7.9.1 RayBiotech Corporate Summary
  7.9.2 RayBiotech Business Overview
  7.9.3 RayBiotech CHST15 Antibody Major Product Offerings
  7.9.4 RayBiotech CHST15 Antibody Revenue in Global Market (2017-2022)
  7.9.5 RayBiotech Key News
7.10 Origene
  7.10.1 Origene Corporate Summary
  7.10.2 Origene Business Overview
  7.10.3 Origene CHST15 Antibody Major Product Offerings
  7.10.4 Origene CHST15 Antibody Revenue in Global Market (2017-2022)
  7.10.5 Origene Key News
7.11 Genetex
  7.11.1 Genetex Corporate Summary
  7.11.2 Genetex Business Overview
  7.11.3 Genetex CHST15 Antibody Major Product Offerings
  7.11.4 Genetex CHST15 Antibody Revenue in Global Market (2017-2022)
  7.11.5 Genetex Key News
7.12 Biobyt
  7.12.1 Biobyt Corporate Summary
  7.12.2 Biobyt Business Overview
  7.12.3 Biobyt CHST15 Antibody Major Product Offerings
  7.12.4 Biobyt CHST15 Antibody Revenue in Global Market (2017-2022)
  7.12.5 Biobyt Key News
7.13 Aviva Systems Biology
  7.13.1 Aviva Systems Biology Corporate Summary
  7.13.2 Aviva Systems Biology Business Overview
  7.13.3 Aviva Systems Biology CHST15 Antibody Major Product Offerings
  7.13.4 Aviva Systems Biology CHST15 Antibody Revenue in Global Market (2017-2022)
  7.13.5 Aviva Systems Biology Key News
7.14 Atlas Antibodies
  7.14.1 Atlas Antibodies Corporate Summary
  7.14.2 Atlas Antibodies Business Overview
  7.14.3 Atlas Antibodies CHST15 Antibody Major Product Offerings
  7.14.4 Atlas Antibodies CHST15 Antibody Revenue in Global Market (2017-2022)
  7.14.5 Atlas Antibodies Key News
7.15 Abbexa Ltd
  7.15.1 Abbexa Ltd Corporate Summary
  7.15.2 Abbexa Ltd Business Overview
  7.15.3 Abbexa Ltd CHST15 Antibody Major Product Offerings
  7.15.4 Abbexa Ltd CHST15 Antibody Revenue in Global Market (2017-2022)
  7.15.5 Abbexa Ltd Key News
7.16 Bioss Antibodies
  7.16.1 Bioss Antibodies Corporate Summary
  7.16.2 Bioss Antibodies Business Overview
  7.16.3 Bioss Antibodies CHST15 Antibody Major Product Offerings
  7.16.4 Bioss Antibodies CHST15 Antibody Revenue in Global Market (2017-2022)
  7.16.5 Bioss Antibodies Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. CHST15 Antibody Market Opportunities & Trends in Global Market
Table 2. CHST15 Antibody Market Drivers in Global Market
Table 3. CHST15 Antibody Market Restraints in Global Market
Table 4. Key Players of CHST15 Antibody in Global Market
Table 5. Top CHST15 Antibody Players in Global Market, Ranking by Revenue (2021)
Table 6. Global CHST15 Antibody Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global CHST15 Antibody Revenue Share by Companies, 2017-2022
Table 8. Global Companies CHST15 Antibody Product Type
Table 9. List of Global Tier 1 CHST15 Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CHST15 Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CHST15 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - CHST15 Antibody Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - CHST15 Antibody Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global CHST15 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - CHST15 Antibody Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - CHST15 Antibody Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global CHST15 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global CHST15 Antibody Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global CHST15 Antibody Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America CHST15 Antibody Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America CHST15 Antibody Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe CHST15 Antibody Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe CHST15 Antibody Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia CHST15 Antibody Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia CHST15 Antibody Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America CHST15 Antibody Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America CHST15 Antibody Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa CHST15 Antibody Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa CHST15 Antibody Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific CHST15 Antibody Product Offerings
Table 32. Thermo Fisher Scientific CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 33. R&D Systems Corporate Summary
Table 34. R&D Systems CHST15 Antibody Product Offerings
Table 35. R&D Systems CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 36. Novus Biologicals Corporate Summary
Table 37. Novus Biologicals CHST15 Antibody Product Offerings
Table 38. Novus Biologicals CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 39. Abcam Corporate Summary
Table 40. Abcam CHST15 Antibody Product Offerings
Table 41. Abcam CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 42. Bio-Rad Corporate Summary
Table 43. Bio-Rad CHST15 Antibody Product Offerings
Table 44. Bio-Rad CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 45. Boster Bio Corporate Summary
Table 46. Boster Bio CHST15 Antibody Product Offerings
Table 47. Boster Bio CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 48. Lifespan Biosciences Corporate Summary
Table 49. Lifespan Biosciences CHST15 Antibody Product Offerings
Table 50. Lifespan Biosciences CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 51. Santa Cruz Biotechnology Corporate Summary
Table 52. Santa Cruz Biotechnology CHST15 Antibody Product Offerings
Table 53. Santa Cruz Biotechnology CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 54. RayBiotech Corporate Summary
Table 55. RayBiotech CHST15 Antibody Product Offerings
Table 56. RayBiotech CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 57. Origene Corporate Summary
Table 58. Origene CHST15 Antibody Product Offerings
Table 59. Origene CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 60. Genetex Corporate Summary
Table 61. Genetex CHST15 Antibody Product Offerings
Table 62. Genetex CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 63. Biobyt Corporate Summary
Table 64. Biobyt CHST15 Antibody Product Offerings
Table 65. Biobyt CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 66. Aviva Systems Biology Corporate Summary
Table 67. Aviva Systems Biology CHST15 Antibody Product Offerings
Table 68. Aviva Systems Biology CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 69. Atlas Antibodies Corporate Summary
Table 70. Atlas Antibodies CHST15 Antibody Product Offerings
Table 71. Atlas Antibodies CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 72. Abbexa Ltd Corporate Summary
Table 73. Abbexa Ltd CHST15 Antibody Product Offerings
Table 74. Abbexa Ltd CHST15 Antibody Revenue (US$, Mn), (2017-2022)
Table 75. Bioss Antibodies Corporate Summary
Table 76. Bioss Antibodies CHST15 Antibody Product Offerings
Table 77. Bioss Antibodies CHST15 Antibody Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. CHST15 Antibody Segment by Type in 2021
Figure 2. CHST15 Antibody Segment by Application in 2021
Figure 3. Global CHST15 Antibody Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global CHST15 Antibody Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CHST15 Antibody Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CHST15 Antibody Revenue in 2021
Figure 8. By Type - Global CHST15 Antibody Revenue Market Share, 2017-2028
Figure 9. By Application - Global CHST15 Antibody Revenue Market Share, 2017-2028
Figure 10. By Region - Global CHST15 Antibody Revenue Market Share, 2017-2028
Figure 11. By Country - North America CHST15 Antibody Revenue Market Share, 2017-2028
Figure 12. US CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 13. Canada CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe CHST15 Antibody Revenue Market Share, 2017-2028
Figure 16. Germany CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 17. France CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 19. Italy CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 20. Russia CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia CHST15 Antibody Revenue Market Share, 2017-2028
Figure 24. China CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 25. Japan CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 28. India CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America CHST15 Antibody Revenue Market Share, 2017-2028
Figure 30. Brazil CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa CHST15 Antibody Revenue Market Share, 2017-2028
Figure 33. Turkey CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 34. Israel CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 36. UAE CHST15 Antibody Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. R&D Systems CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novus Biologicals CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abcam CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bio-Rad CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boster Bio CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Lifespan Biosciences CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Santa Cruz Biotechnology CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. RayBiotech CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Origene CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Genetex CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Biobyt CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Aviva Systems Biology CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Atlas Antibodies CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Abbexa Ltd CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Bioss Antibodies CHST15 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)